Hematopoietic Stem Cell Transplantation for Leukemia

Author(s):
Wayne, A.S.; Baird, K.; Egeler, R.M.
Published
2010
Publication type
Article / Letter to editor

Abstract

Leukemia represents the most common pediatric malignancy, accounting for approximately 30% of all cancers in children less than 20 years of age. Most children diagnosed with leukemia are cured without hematopoietic stem cell transplantation (HSCT), but for some high-risk subgroups, allogeneic HSCT plays an important role in their therapeutic approach. The characteristics of these high-risk subgroups and the role of HSCT in childhood leukemias are discussed.

Leukemia Hematopoietic stem cell transplantation HSCT Pediatric acute lymphoblastic-leukemia bone-marrow-transplantation acute myeloid-leukemia pediatric-oncology-group childrens-cancer-group juvenile myelomonocytic leukemia acute promyelocytic leukemia acute myelogenous leukemia hla-identical siblings total-body irradiation
Date issued
2010-02-28
Language
English
Is part of
Pediatric Clinics of North America (2010), Vol. 57, no. 1, p. 1
hdl
1887/109301